Association between telomere length and BCL2 gene rearrangements in low- and high-grade non-Hodgkin lymphomas

Cancer Genetics and Cytogenetics

Volumn 171, Issue 1, 2006, Pages 1-8

  Cottliar, Alejandra Silvina Haydeé ^a   Noriega, María Fernanda ^a   Narbaitz, Marina ^a   Rodríguez, Andrea ^a   Slavutsky, Irma Rosa ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD CELL; BONE MARROW CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT; TELOMERE;

ADULT; AGED; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA, NEOPLASM; ELECTROPHORESIS, AGAR GEL; FEMALE; GENE REARRANGEMENT; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; TELOMERE;

EID: 33750360887     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.05.016     Document Type: Article

References (52)

1. Bacchetti S. Telomere maintenance in tumour cells. Cancer Surv 28 (1996) 197-216
2. Goyns M.H., and Lavery W.L. Telomerase and mammalian ageing: a critical appraisal. Mech Ageing Dev 114 (2000) 69-77
3. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., and de Lange T. Mammalian telomeres end in a large duplex loop. Cell 97 (1999) 503-514
4. Deng W., Tsao S.W., Guan X.Y., Lucas J.N., Si H.X., Leung C.S., Mak P., Wang L.D., and Cheung A.L. Distinct profiles of critically short telomeres are a key determinant of different chromosome aberrations in immortalized human cells: whole-genome evidence from multiple cell lines. Oncogene 23 (2004) 9090-9101
5. Harris N.L. Mature B-cell neoplasms. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours (2001), IARC Press, Lyon 118-187
6. Parkin D.M., Whelan S.L., Ferlay J., Raymond L., and Young J. Cancer incidence in five continents. Vol. 7. IARC Scientific Publication 143 (1997), IARC Press, Lyon
7. Gine E., López-Guillermo A., Montoto S., and Bosch F. FLIPI and histological subtype of the most important predicting factors of histological transformation in follicular lymphoma. Ann Oncol 16 (2005) 26
8. Cleary M.L., and Sklar J. Nucleotide sequence of a t(14;18) chromosome breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A 82 (1985) 7439-7441
9. Cleary M.L., Galili N., and Sklar J. Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 164 (1986) 315-320
10. Akasaka T., Akasaka H., Yonetani N., Ohno H., Yamabe H., Fukuhara S., and Okuma M. Refinement of the BCL-2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets. Genes Chromosomes Cancer 21 (1998) 17-19
11. Albinger-Hegyi A., Hochreutener B., Abdou M.T., Hegyi I., Dours-Zimmermann M.T., Kurrer M.O., Heitz P.U., and Zimmermann D.R. High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection. Am J Pathol 160 (2002) 823-832
12. Noriega M.F., De Brasi C., Narbaitz M., and Slavutsky I. Incidence of BCL-2 gene rearrangements in Argentinean non-Hodgkin lymphoma patients: increased frequency of breakpoints outside of MBR and MCR. Blood Cells Mol Dis 32 (2004) 232-239
13. Reed J.C., Miyashita T., Takayama S., Wang H.G., Sato T., Krajewski S., Aime-Sempe C., Bodrug S., Kitada S., and Hanada M. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 60 (1996) 23-32
14. Saintigny Y., Dumay A., Lambert S., and Lopez B.S. A novel role for the Bcl-2 protein family: specific suppression of the RAD51 recombination pathway. EMBO J 20 (2001) 2596-2607
15. Youn C.K., Cho H.J., Kim S.H., Kim H.B., Kim M.H., Chang I.Y., Lee J.S., Chung M.H., Hahm K.S., and You H.J. Bcl-2 expression suppresses mismatch repair activity through inhibition of E2F transcriptional activity. Nat Cell Biol 7 (2005) 137-147
16. Carbone P.P., Kaplan H.S., Musshoff K., Smithers D.W., and Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31 (1971) 1860-1861
17. Mann R.B., and Berard C.W. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol 1 (1983) 187-192
18. Cottliar A., Pedrazzini E., Corrado C., Engelberger M.I., Narbaitz M., and Slavutsky I. Telomere shortening in patients with plasma cell disorders. Eur J Haematol 71 (2003) 334-340
19. Gribben J.G., Freedman A.S., Woo S.D., Blake K., Shu R.S., Freeman G., Longtine J.A., Pinkus G.S., and Nadler L.M. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78 (1991) 3275-3280
20. Remes K., Norrback K.-F., Rosenquist R., Mehle C., Lindh J., and Roos G. Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br J Cancer 82 (2000) 601-607
21. Hemann M.T., Strong M.A., Hao L.Y., and Greider C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107 (2001) 67-77
22. Gisselsson D., Jonson T., Yu C., Martins C., Mandahl N., Wiegant J., Jin Y., Mertens F., and Jin C. Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres. Br J Cancer 87 (2002) 202-207
23. Temperani P., Giacobbi F., Gandini G., Torelli U., and Emilia G. Chromosome rearrangements at telomeric level in hematologic disorders. Cancer Genet Cytogenet 83 (1995) 121-126
24. Ladetto M., Compagno M., Ricca I., Pagano M., Rocci A., Astolfi M., Drandi D., di Celle P.F., Dell′aquila M., Mantoan B., Vallet S., Pagliano G., De Marco F., Francese R., Santo L., Cuttica A., Marinone C., Boccadoro M., and Tarella C. Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders. Blood 103 (2004) 4644-4649
25. Slagboom P.E., Droog S., and Boomsma D.I. Genetic determination of telomere size: a twin study of three age groups. Am J Hum Genet 55 (1994) 876-882
26. Mondello C., Petropoulou C., Monti D., Gonos E.S., Franceschi C., and Nuzzo F. Telomere length in fibroblasts and blood cells from healthy centenarians. Exp Cell Res 10 (1999) 234-242
27. Lossos I.S., and Levy R. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biol 13 (2003) 191-202
28. Boonstra R., Bosga-Bouwer A., Mastick M., Haralambieva E., Conradie J., van den Beg F., van den Berg A., and Poppema S. Identification of chromosomal copy number changes associated with transformation of follicular lymphoma to diffuse large B-cell lymphoma. Hum Pathol 34 (2003) 915-923
29. Yano T., Jaffe E.S., Longo D.L., and Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood 80 (1992) 758-767
30. Lossos I.S., Alizadeh A.A., Diehn M., Warnke R., Thorstenson Y., Oefner P.J., Brown P.O., Botstein D., and Levy R. Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci U S A 99 (2002) 8886-8891
31. Lossos I.S., and Levy R. Higher-grade transformation of follicular center lymphoma is associated with somatic mutation of the 5′ noncoding regulatory region of the BCL-6 gene. Blood 96 (2000) 635-639
32. Matolcsy A., Casali P., Warnke R.A., and Knowles D.M. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated BCL-2 gene. Blood 88 (1996) 3937-3944
33. INK4A gene inactivation by deletion, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 9 (1998) 2977-2984
34. Elenitoba-Johnson K.S., Gascoyne R.D., Lim M.S., Chhanabai M., Jaffe E.S., and Raffeld M. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 91 (1998) 4677-4685
35. Elenitoba-Johnson K.S., Jenson S.D., Abbott R.T., Palais R.A., Bohling S.D., Lin Z., Tripp S., Shami P.J., Wang L.Y., Coupland R.W., Buckstein R., Perez-Ordoñez B., Perkins S.L., Dube I.D., and Lim M.S. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci U S A 100 (2003) 7259-7264
36. Lo Coco F., Gaidano G., Louie D.C., Offit K., Chaganti R.S., and Dalla-Favera R. P53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82 (1993) 2289-2295
37. Sander C.A., Yano T., Clark H.M., Harris C., Longo D.L., Jaffe E.S., and Rafeld M. p53 mutation is associated with progression in follicular lymphoma. Blood 82 (1993) 1994-2004
38. Brummendorf T.H., Holyoake T.L., Rufer N., Barnett M.J., Schulzer M., Eaves C.J., Eaves A.C., and Lansdorp P.M. Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood 95 (2000) 1883-1890
39. Drummond M.W., Hoare S.F., Monaghan A., Graham S.M., Alcorn M.J., Keith W.N., and Holyoake T.L. Dysregulated expression of the major telomerase components in leukaemic stem cells. Leukemia 19 (2005) 381-389
40. Ohyashiki J.H., Ohyashiki K., Fujimura T., Kawakubo K., Shimamoto T., Iwabuchi A., and Toyama K. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 54 (1994) 3557-3560
41. Boultwood J., Fidler C., Kusec R., Rack K., Elliott P.J., Atoyebi O., Chapman R., Oscier D.G., and Wainscoat J.S. Telomere length in myelodysplastic syndromes. Am J Hematol 56 (1997) 266-271
42. Zelenetz A.D., Chu G., Galili N., Bangs C.D., Horning S.J., Donlon T.A., Cleary M.L., and Levy R. Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis. Blood 78 (1991) 1552-1560
43. Vaandrager J.W., Schuuring E., Raap T., Philippo K., Kleiverda K., and Kluin P. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes. Genes Chromosomes Cancer 27 (2000) 85-94
44. Lopez-Guillermo A., Cabanillas F., McDonnell T.I., McLaughlin P., Smith T., Pugh W., Hagemeister F., Rodriguez M.A., Romaguera J.E., Younes A., Sarris A.H., Preti H.A., and Lee M.-S. Correlation of BCL-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma. Blood 93 (1999) 3081-3087
45. Sehn L.H., Gascoyne R.D., Connors J.M., Klasa R.J., and Horsman D.E. Comparison of t(14;18) positive and t(14;18) negative follicular lymphoma (FL): clinical characteristics, outcome and cytogenetics. [Abstract]. Blood 96 (2000) 574a
46. Jardin F., Gaulard P., Buchonnet G., Contentin N., Lepretre S., Lenain P., Stamatoullas A., Picquenot J.M., Duval C., Parmentier F., Tilly H., and Bastard C. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics. Leukemia 16 (2002) 2309-2317
47. Horsman D.E., Okamoto I., Ludkovsky O., Le N., Harder L., Gesk S., Siebert R., Chhanabahai M., Sehn L., Connors J.M., and Gascoyne R.D. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes. Br J Haematol 120 (2003) 424-433
48. Nanjangud G., Naresh K., Teruya-Feldstein J., Olshen A.B., Wilton A.S., Parsa N.Z., Rao P.H., Filippa D.A., Hegde A., Hedvat C.V., Jhanwar S.C., Mehra S., Johansson B., Mitelman F., Zelenetz A.D., and Chaganti R.S.K. Cytogenetic analysis of follicular lymphoma: Chromosome instability associated with t(14;18)(q32;q21) positive and negative subsets, histology and transformations. [Abstract]. Blood 102 (2003) 847a
49. Montoto S., Lopez-Guillermo A., Colomer D., Esteve J., Bosch F., Ferrer A., Villamor N., Moreno C., Campo E., and Montserrat E. Incidence and clinical significance of Bcl-2/IgH rearrangements in follicular lymphoma. Leuk Lymphoma 44 (2003) 71-76
50. Buchonnet G., Jardin F., Jean N., Bertrand P., Parmentier F., Tison S., Lepretre S., Contentin N., Lenain P., Stamatoullas-Bastard A., Tilly H., and Bastard C. Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?. Leukemia 16 (2002) 1852-1856
51. Hahn W.C., and Weinberg R.A. Rules for making human tumor cells. N Engl J Med 347 (2002) 1593-1603 [Erratum in: N Engl J Med 2003;348:674]
52. Saretzki G. Telomerase inhibition as cancer therapy. Cancer Lett 194 (2003) 209-219